Guerbet
Guerbet (Euronext: GBT) is a France-based manufacturer of contrast agents used in medical imaging. The company was founded in 1926 by André Guerbet, the son of Marcel Guerbet who in 1901 discovered Lipiodol – the first iodinated X-ray contrast agent.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Dotarem | Gadoterate meglumine | 2013-03-20 | — | |
| Elucirem | Gadopiclenol | 2022-09-21 | 2028-2040 | — |
| Hexabrix | Ioxaglate meglumine, Ioxaglic acid | 1985-07-26 | — | |
| Lipiodol | Ethiodized oil | 1982-01-01 | — | |
| Oxilan | Ioxilan | 1995-12-21 | — |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use